Centre to require pharmas to distinguish biologics from synthetics



The government’s proposed regulatory intervention aims to address ambiguity around drugs, such as semaglutide, that can be produced chemically as well as biologically.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *